Agoracom Blog

CLIENT FEATURE: Tartisan Nickel (TN:CSE) Advancing the Kenbridge Nickel Mine – A Project Designed for Small Cap Success $TN.ca $NICO.ca $RNX.ca $TSLA $NOB.ca $SHL.ca $CNC.ca

Posted by AGORACOM at 11:07 AM on Tuesday, September 1st, 2020

Investment Highlights

  • Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
    • The deepest hole extends to 838.4 metres, intersecting mineralization grading 4.25% nickel and 1.38% copper over 10.7 metres
    • The deposit remains open at depth
  • Tartisan completed a Spectral Analysis Survey that identified the Kenbridge Deposit, and has shown a possible extension and three additional trends
  • Owns 17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property and are drilling their Iska Iska Pollymetallic project in Bolivia
    • Tartisan currently owns close to 4 million ELO shares  
  • Tartisan owns close to 1,700,000 shares in Class 1 Nickel (CSE:NICO)
    • Tartisan vended the Alexo- Kelex asset to Class 1 Nickel, who recently listed on CSE

Kenbridge Ni Project (ON, Canada)

  • Advanced  stage  deposit  remains open  in  three  directions,  is  equipped with a 623m  deep  shaft  and  has  never  been  mined
  • Preliminary  Economic Assessment completed and updated returned robust project 
    economics and operating costs including  a  NPV  of  C$253M  and  cash costs of US$3.47/lb of nickel net of  copper credits
  • Plans for Kenbridge include updating PEA, advancing the project through to feasibility and exploring the open mineralization at depth

Recent News

  • Company has completed a Spectral Analysis Survey
  • Survey covered the patented and single-cell mining claims that make up the historic land position which contains the Kenbridge Deposit and the surrounding area, identifying several new exploration targets not only for nickel, copper, cobalt, but also for potential gold occurrences
  • Analysis Survey shows the distribution and intensity of up to 304 minerals, with the first pass showing up to 16 minerals
  • Each mineral can be classified into an exploration relevance for base metals, precious metals and industrial metals

Tartisan CEO Mark Appleby said, “the survey picked out the Kenbridge Deposit, and has shown the possible extension to the Kenbridge Deposit and three additional trends that relate directly to underlying geology and structure implicit in the Kenbridge Deposit. Of significant interest, the survey found two gold trends as well, which include the Violet and Nina historic gold occurrences. One of the occurrences is almost 54 hectares in size and covers almost all of three of our staked claims on the border of the Kenbridge property.”

DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Tartisan Nickel | Comments Off on CLIENT FEATURE: Tartisan Nickel (TN:CSE) Advancing the Kenbridge Nickel Mine – A Project Designed for Small Cap Success $TN.ca $NICO.ca $RNX.ca $TSLA $NOB.ca $SHL.ca $CNC.ca

Why Small Cap Gold Investors Need To Take Notice of Ohio Pension Fund Entering The Gold Market $AMK.ca $AFF.ca $DGO.ca $CDG.ca $LN.ca $LAB.ca $SX.ca $TAJ.ca

Posted by AGORACOM at 9:54 AM on Tuesday, September 1st, 2020

Small cap investors should take notice of the following small cap gold exploration companies after the Ohio Police & Fire Pension Fund (OP&F) approved a 5% allocation into gold in a move to diversify its portfolio and hedge against the risk of inflation. This may not sound like much, but it may be the first of many pension funds to follow as they seek to protect their pension assets. The OP&F fund currently holds about $16 billion in assets under management and believe gold will give the portfolio a strong diversifier to its growth-oriented investments as well as provide an effective hedge against inflation

More and more pensions are going to need to protect themselves against rising inflation and the falling value of currencies and 5% from every fund poses an incredible amount of purchasing power for the gold market to sustain.

Rising gold prices boost demand, as witnessed by Warren Buffett’s Berkshire Hathaway surprising gold investors after buying nearly 21 million shares of Barrick Gold. The first time ever in the funds history.

If the worlds largest funds are finding value in the gold market, small cap investors need to pay attention to the following Agoracom clients poised for success.

 (TSXV: AMK)

American Creek owns a 20% Carried Interest to Production at the Treaty Creek Project in the Golden Triangle. 2020’s first hole is the best yet, intersecting 973 Meters Averaging 0.845 gram per ton Equivalent, From Hole GS-20-57, Including 1.40 gpt AuEq Over 217.5 Meters. Eric Sprott believes Treaty Creek may contain over 30 million ounces. Initial resource report expected late 2020 from project operator Tudor Gold.                  

Hub On AGORACOM

——–

(TSXV: AFF)

Affinity controls 2 projects, The West Timmins Gold and The Regal where and Affinity just announced that drilling has begun targeting several major geophysical anomalies as well as three historic small-scale past producing mines. Past results include 11.10 meter interval of 143.29 g/t silver which included a 0.55 meter interval of 2,612.0 g/t silver.

The West Timmins Gold property is located near Timmins, Ontario, Canada and adjoins Melkior’s Carscallen project. The first drill hole has been completed and assays from that first hole are expected to be received by the Corporation within the next two weeks.

Hub On AGORACOM

——–

(TSXV: DGO)

Durango is positioned for discovery with a 100% interest in strategically located properties in the Windfall Lake gold camp in the Abitibi region of Quebec, named Trove and Barry. Osisko is currently drilling the Lynx Project close to Durango’s property border. Durango is currently finalizing its drill plan for 2020.

Hub On AGORACOM

(CDG: TSXV)

Candente owns a large, economic, copper ore body in Peru waiting to be mined. Cañariaco Norte is a 100% owned feasibility-stage porphyry copper deposit containing 7.5 billion pounds of copper and has had multiple scientific studies propelling it along the way toward production. Strengthened by Goldman Sachs belief it is one of the top 80 copper deposits yet to be exploited and strategically guided by Australian Iron Ore giant Fortescue’s 19% inside ownership, Candente has the lowest quartile production costs slated for development.

Hub On AGORACOM

——–

(TSXV: LAB)

Labrador Gold explores for prospective gold projects in Eastern Canada. The Kingsway project is the current focus in Newfoundland, along strike of New Found Gold’s discovery of 92.86 g/t Au over 19.0 metres on their Queensway property. Field crews have started the 2020 exploration program on the Kingsway Property. Labrador also holds the Hopedale and Ashuanipi district scale gold exploration properties.

Hub On AGORACOM

——–

(TSX: LN)


Loncor Resources (LN: TSX / Q: LONCF /) is an excellent gold explorer that is 100% focused on Africa, where they have already discovered over 3 million ounces of gold …. with plans to find even more.

World renown gold miner Newmont has a market capitalization of $50 Billion and owns 8% of Loncor.    Resolute Mining of Australia has a market capitalization of $1.5 Billion and owns 26% of Loncor 

Joint Venture on all of Loncor’s remaining land with Barrick Gold, the $53 Billion Company whose mandate is to find a Tier 1 asset. On Loncor ground

Hub On AGORACOM

——–

SX has a “Eco-Green’ approach to the mining business. It creates eco-friendly mining solutions through technology to grow its business and has developed 4 separate and distinct avenues to create an ideal growth company for the ecological requirements 21st mining will face. Currently focused on exploring for gold in Iceland while developing processing technologies to reduce the environmental impact of mining activities.  

Hub On AGORACOM

——–

(TSXV: TAJ)

Tajiri Resources Corp is exploring for world class gold deposits in Guyana with 2 exploration properties that could each wield major discoveries, the Gargantuan and Epeius projects. Supported by management that have a track record of discovery with almost 20 million ounces, mostly in Guyana

Hub On AGORACOM

FULL DISCLOSURE: All companies are advertising client of AGORA Internet Relations Corp.

Tags: , , , , ,
Posted in Affinity Metals, All Recent Posts, American Creek Resources Ltd., Candente Gold, Durango Resources, Labrador Gold, Loncor, St Georges Eco-Mining Technologies, Tajiri Resources | Comments Off on Why Small Cap Gold Investors Need To Take Notice of Ohio Pension Fund Entering The Gold Market $AMK.ca $AFF.ca $DGO.ca $CDG.ca $LN.ca $LAB.ca $SX.ca $TAJ.ca

Primo Nutraceuticals Inc. $PRMO.ca and Dan Duquette Former MLB Executive Enter into Letter of Intent for the Development of a Global Supply of #PPE products & Primo Hand Sanitizer

Posted by AGORACOM-JC at 8:50 AM on Tuesday, September 1st, 2020
  • Entered into a Letter of Intent with Duquette Consulting LLC (the “LOI”), a company owned by Dan Duquette.
  • Dan Duquette is a twice named Major League Baseball (MLB) Executive of the Year and former Executive Vice-President of the Baltimore Orioles, General Manager of the Montreal Expos, Boston Red Sox, and Milwaukee Brewers
  • Dan Duquette has joined forces with Primo Nutraceuticals to partner in the development, sourcing and the global supply of personal protective equipment products including Primo’s hand sanitizer

VANCOUVER, British Columbia, Sept. 01, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce it has entered into a Letter of Intent with Duquette Consulting LLC (the “LOI”), a company owned by Dan Duquette. Dan Duquette is a twice named Major League Baseball (MLB) Executive of the Year and former Executive Vice-President of the Baltimore Orioles, General Manager of the Montreal Expos, Boston Red Sox, and Milwaukee Brewers (https://en.wikipedia.org/wiki/Dan_Duquette). Dan Duquette has joined forces with Primo Nutraceuticals to partner in the development, sourcing and the global supply of personal protective equipment (“PPE”) products including Primo’s hand sanitizer.

In June 2020 Primo received its first shipment of its lemon hand sanitizer and immediately began sending out samples to procurement departments, receiving positive feedback regarding the quality of the product. Duquette Consulting & their affiliates will help Primo in marketing the hand sanitizer via their partnership channels, marketing brochures & e-commerce sites exposing the Company’s products on a global scale. As Primo is expanding into the Canadian market the Company must have an MDEL (Medical Device Establishment License) to comply with the regulations of Health Canada relating to companies seeking to sell, distribute, manufacture or import medical equipment in Canada. Primo and Duquette Consulting will work towards securing the necessary licenses required to sell nitrile gloves, N95 surgical masks & KN95 masks and gowns. The Company is extremely focused on developing the right partnerships that will encourage the Company’s growth into the market sector of health and wellness. Primo is extremely optimistic that building these strategic types of relationships will prove fruitful for the Company and its shareholders in the very near future.

Duquette Consulting entered the PPE market by sourcing and selling products and supplies at a government & state level to help in the fight against COVID-19, securing, shipping and recently delivering over 5 million masks to the State of Maryland in the United States (the “U.S”). Duquette Consulting partnered with Crowley Worldwide (www.crowley.com) a large logistics conglomerate with over USD $2 billion in annual revenue, offering services to the U.S. Department of Defense, the Department of Homeland Security and other state and federal agencies in the U.S.; top medical equipment suppliers, with financial backing by Citibank. A Duquette Consulting press release is located at the following link: https://dcppe.net/case-study/

The strategic partnership contemplated in the LOI is extremely beneficial for Primo, opening the doors to potential massive orders for the Company’s hand sanitizer worldwide. With the recent issuance of a Government Procurement number to Primo by the Canada Revenue Agency and the LOI with Duquette Consulting LLC, Primo could soon be able to bid on government tenders not only for hand sanitizer, but for N95 surgical masks, KN95 masks, nitrile surgical gloves and gowns. All PPE products would meet the certification standards of the market place including the FDA, CDC, MOD and NIOSH approval requirements.

Richard Cindric, CEO of Primo comments:“We are excited to partner with Mr. Duquette. Together we will provide our line of hand sanitizer to Dan’s already established PPE supply chain processes and distribution network of companies across the U.S.A. and abroad.”

Andy Jagpal, President of Primo comments: “We are extremely pleased to partner with Mr. Duquette to develop a global supply chain of personal protection equipment. We look forward to working with Dan and his team.”

Dan Duquette, CEO Duquette Consulting LLC comments: “Our new partnership with Primo contemplated in the LOI will afford Duquette Consulting the opportunity to broaden our offerings to those in need of PPE.  Our recent success in supplying the State of Maryland with over five millions NIOSH approved Surgical Masks is a prime example of our ability to meet the need of institutional buyers who are looking for both quality products from a reputable firm who can deliver in an expedient and cost effective manner. As well as adding in our ability to finance our transactions is a significant differentiator that separates us in the PPE marketplace.”

Joel DeBellefeuille, Director of Primo comments: ”I’ve known Dan for a few years now and I couldn’t be happier to continue working and collaborating with him on amazing deals and partnerships. This is a major plus for Primo and its shareholders. Dan is an extremely influential person with a network of people spanning the globe.”

About Dan Duquette

Dan Duquette is a MLB veteran (Major League Baseball) Executive whose leadership built winning teams and enterprise value of club and media assets over an 18 year career. Successfully executing plans to immediately turn around the Montreal Expos, Boston Red Sox and Baltimore Orioles as entertaining teams to grow fan base, improve revenues, expand market share and improve content distribution. He is also the founder of the Dan Duquette Sports Academy. He has twice been named the Major League Baseball Executive of the Year by Sporting News in 1992 with the Expos and in 2014 with the Baltimore Orioles.

About Duquette Consulting LLC

Duquette Consulting is a management consulting company. With the advent of the worldwide pandemic, we have focused our efforts to help combat the effects of COVID19. In doing so, we established a network of international companies and entities who specialize in supporting the emergency management community in times of crisis. As part of our covid-19 initiative, Duquette Consulting manages and coordinates the procurement and acquisition for both the public and private sectors, domestically and internationally of Personal Protection Equipment (PPE). Our partnership has banking relationships that allow Duquette Consulting’s Partnership group the ability to finance large scale supply of PPE items such as masks, gloves and gowns. Our products are of the highest quality and meet the certifications standards of the marketplace including the FDA, CDC, MOD, and NIOSH approval requirements.

About Primo Nutraceuticals

Primo Nutraceuticals Inc. (“Primo” or the “Company”) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

Andy Jagpal
President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected].

To learn more about what this news means to the shareholders visit:

www.primonutraceuticals.com
www.twitter.com/Prmoinc
www.thrivecbd.com
www.mariannacorp.com
www.dcppe.net

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.

Tags: , , , , , , ,
Posted in PRIMO Nutraceuticals Inc. | Comments Off on Primo Nutraceuticals Inc. $PRMO.ca and Dan Duquette Former MLB Executive Enter into Letter of Intent for the Development of a Global Supply of #PPE products & Primo Hand Sanitizer

TGS Esports Announces Intent to Acquire Leading Competitive #Esports Platform, Pepper Esports $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 8:45 AM on Tuesday, September 1st, 2020
TGS-square
  • Executed a letter of intent dated August 28, 2020 to acquire Pepper Esports Inc.
  • Pepper platform offers an advanced suite of tools for league operators, tournament operators, and venue owners to setup and manage esports communities and run world class events
  • These include key innovations, such as Pepper’s automatic game scoring technology, which uses its patent pending AI engine and saves event organizers hundreds of hours of setup time, while also providing players and attendees with a vastly improved experience.

VANCOUVER, BC, Sept. 1, 2020  – TGS Esports Inc. (“TGS” or the “Company“) (TSX-V: TGS) is pleased to announce that it has taken the next step in its growth strategy to provide a consolidated end to end esports experience to players and tournament organizers by executing a letter of intent dated August 28, 2020 (the “LOI“) to acquire Pepper Esports Inc. (“Pepper“), a leading competitive esports platform (the “Acquisition“). In addition, the Pepper executive team, Guy Halford-Thompson, Jackson Warren and Ben Hoffman, with over a decade of combined experience in growing early stage companies in the public markets, are expected to join TGS executive team on the closing of the Acquisition (the “Closing“). Under the terms of the LOI, TGS is expected to acquire all of the outstanding securities of Pepper by way of a three-cornered amalgamation.

The Pepper platform offers an advanced suite of tools for league operators, tournament operators, and venue owners to setup and manage esports communities and run world class events. These include key innovations, such as Pepper’s automatic game scoring technology, which uses its patent pending AI engine and saves event organizers hundreds of hours of setup time, while also providing players and attendees with a vastly improved experience.

Transaction Highlights

  • Develop New Revenue Streams – the Acquisition is expected to provide TGS with diverse new online revenue streams that include data monetization, payment processing and recurring subscription revenue.
  • Expanded Consumer and Business Base – the combined company will have the ability to acquire users from all over the globe through tournaments of any kind.
  • Highly Accomplished and Experienced Team – the completion of the Acquisition will add a team with over a decade of combined experience in growing early stage companies in the public markets.

“Rather than sending our players to third party platforms for online events, and missing out on key revenue, we will now be able to keep players within our ecosystem while also generating revenue directly from the Pepper platform,” said Spiro Khouri, CEO of TGS. “This acquisition brings an important technology platform to TGS, making our business model scalable, global, and with defensible IP.”

“This acquisition will fast track our ability to scale the Pepper platform by leveraging the existing customers and expertise of the TGS team, and we hope to bring accelerated revenue growth to TGS once the Pepper platform is fully launched,” said Guy Halford-Thompson, CEO of Pepper. “Becoming part of TGS is a big milestone for the company.”

The global market for esports tournaments is expected to be USD $1.598 billion by 2023 according to an August 2020 report by Statista, with few dominant game-agnostic service providers that are publicly traded.

Summary of Acquisition

The LOI sets out the principal terms on which the parties have agreed to complete the Acquisition. The parties have agreed to negotiate in good faith to formalize a definitive agreement (the “Definitive Agreement“) on or before October 30, 2020, and they have agreed to a mutual exclusivity and due diligence period expiring 45 days from the date of the LOI.

On Closing, the Company will acquire all of the issued and outstanding common shares of Pepper (the “Pepper Shares“) in consideration for 43,385,664 common shares of the Company (each a “TGS Share“, and such TGS Shares issued as consideration for the Acquisition, the “Consideration Shares“) at a deemed price of $0.14 per Consideration Share for aggregate deemed consideration of approximately $6,073,993. The Consideration Shares will be subject to a contractual lock-up, with 20% of the Consideration Shares being released on the Closing and a further 20% being released every six months thereafter.

Each outstanding security of Pepper that is convertible or exchangeable for Pepper Shares will be exchanged for corresponding securities that are convertible or exchangeable for TGS Shares on substantially the same economic conditions.

On Closing, Pepper will have the right to appoint a nominee to the board of directors of the Company.

The LOI contains, and the Definitive Agreement will provide for, customary representations, warranties and covenants including non-solicitation and a right to match any superior proposal. Completion of the Acquisition remains subject to a number of conditions, including: (i) the approval of the Acquisition by the shareholders of Pepper, (ii) the completion of satisfactory due diligence, (iii) the approval of the boards of directors of the Company and Pepper, (iv) the execution of the Definitive Agreement, (v) obtaining all required consents, waivers and approvals, including the approval of the TSX Venture Exchange, and (vi) other closing conditions customary for transactions of this nature.

Haywood Securities Inc. has acted as a financial advisor to Pepper in connection with the Acquisition.

The Company and Pepper deal at arm’s length with each other, and the Acquisition is not expected to result in a change of control of the Company.  A finder’s fee in an amount to be determined at a later time may be payable in connection with the Acquisition, subject to compliance with applicable securities laws and the approval of the TSXV.

About Pepper Esports Inc.

Pepper is a leading esports platform provider that offers an advanced platform to create and manage communities of players, organizers, spectators and sponsors, all in one place.  By working closely with event organizers and live venue operators over the last two years, Pepper has developed a suite of advanced tools to manage esports communities, run world class esports and operate physical gaming venues.

Pepper’s key technologies include its patent pending AI engine, which automatically captures game data to create a tournament experience that extends beyond live gameplay and includes highly demanded features such as global leaderboards, player profiles and statistics, new tournament discovery and digital wallets.

About TGS Esports Inc.

TGS Esports Inc. is the parent company of Myesports. Myesports was created in Vancouver, British Columbia, in 2018, and is an esports organization focused on providing and hosting esports events, tournaments, and leagues at both the amateur and professional levels both online and in person. Myesports is the operator of Canada’s first dedicated esports arena, The Gaming Stadium, located in Richmond, British Columbia, which opened in June 2019.  Since its inception, Myesports has hosted esports events for games such as League of Legends and Fortnite, as well as organized and hosted the Pinnacle event at the River Rock Casino and the Burnaby Festival of Learning. Myesports also hosts regular online tournaments as well as provides high quality broadcast production for any event. For more information, visit www.thegamingstadium.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

On behalf of the Board of Directors

“Spiro Khouri“

Spiro Khouri, CEO
TGS Esports Inc.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including with respect to: Guy Halford-Thompson, Jackson Warren and Ben Hoffman joining the TGS team, that the Acquisition will allow the Company to keep players within its ecosystem while also generating revenue directly from the Pepper platform, that the Acquisition will make the Company’s business model scalable, global, and with defensible IP, that the Acquisition will fast track Pepper’s ability to scale the Pepper platform by leveraging the existing customers and expertise of the TGS team the execution of the Definitive Agreement and the terms of such Definitive Agreement, the completion of the Acquisition, the acceptance of the TSX Venture Exchange, the global market for esports tournaments and that a finder’s fee may be payable in connection with the Acquisition. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. The risks include the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic and other risks that are customary to transactions of this nature. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them.

This press release is not an offer of the securities for sale in the United States. The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an exemption from registration.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful.

Tags: , , , , , , , ,
Posted in Featured, TGS ESports Inc. | Comments Off on TGS Esports Announces Intent to Acquire Leading Competitive #Esports Platform, Pepper Esports $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

PyroGenesis $PYR.ca Participates in $HPQ.ca Non-Brokered Private Placement Financing $IDK.ca $DUK $XEL $NEE

Posted by AGORACOM-JC at 8:26 AM on Tuesday, September 1st, 2020
  • Announced that it is closing a non-brokered private placement of 4,500,000 units (“Unit”) at $0.60 per Unit for gross proceeds of $2,700,000 with the two following Placees:
  • PyroGenesis Canada Inc, (TSX-V: PYR), a high-tech company, that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products has subscribed for 4,000,000 units in the placement for a gross proceeds of $2,400,000;
  • THREED CAPITAL INC. (CSE: IDK) (OTTCBB: IDKFF) a Canadian venture capital firm that invests in disruptive companies has subscribed for 500,000 units in the placement for a gross proceeds of $300,000.

MONTREAL, Sept. 01, 2020 — HPQ Silicon Resources Inc. (“HPQ” or “the Company”) TSX-V: HPQ; FWB: UGE; Other OTC : URAGF; is pleased to announce that it is closing a non-brokered private placement of 4,500,000 units (“Unit”) at $0.60 per Unit for gross proceeds of $2,700,000 with the two following Placees:

  • PyroGenesis Canada Inc, (TSX-V: PYR), a high-tech company, that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products has subscribed for 4,000,000 units in the placement for a gross proceeds of $2,400,000;
  • THREED CAPITAL INC. (CSE: IDK) (OTTCBB: IDKFF) a Canadian venture capital firm that invests in disruptive companies has subscribed for 500,000 units in the placement for a gross proceeds of $300,000.

“This transaction is a further demonstration of the strength of the HPQ – PyroGenesis cooperation as we develop both the PUREVAP™ Quartz Reduction Reactor (QRR) and the PUREVAP™ Nano Silicon Reactor (NSiR) processes.  Furthermore, the participation of legendary Venture Capital Financier Sheldon Inwentash in a Private Placement that values HPQ market capitalization over the $150 Million threshold is strong vote of confidence in what we are doing,” said Bernard Tourillon, President & CEO of HPQ Silicon. “Our PUREVAP™ processes open up unique business opportunities with multibillion-dollar addressable markets for HPQ, PyroGenesis and our shareholders, as we strive to deliver the critical Silicon nano-materials required by the surging Li-ion battery market and other renewable energy sectors.”

“It is indeed a pleasure to participate in this private placement and increase our position in HPQ,” said P. Peter Pascali CEO and Chairman of PyroGenesis Canada Inc. “Not only do we find this to be a unique opportunity to invest in a business that has enormous potential for growth, but one that is supported by a visionary management and Board. We are confident that this investment will play out very well for us and our investors, and we look forward to consider adding to our position should the opportunity arise in the future.”

In addition to participating in the Placement, HPQ is pleased to announce that THREED Capital Inc CEO Sheldon Inwentash has agreed to act as a strategic advisor to HPQ management as we embark in the start of this new and exciting phase of our development.

Placement Terms: Each Unit will be comprised of one (1) common share and one (1) common share purchase warrant (“Warrant”) of the Company. Each Warrant will entitle the Subscribers to purchase one common share of the capital stock of the Company at an exercise price of $ 0.61 for a period of 36 months from the date of closing of the placement. Each share issued pursuant to the placement will have a mandatory four (4) month and one (1) day hold period from the date of closing of the placement. The Placement is subject to standard regulatory approvals.

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) presently under way. Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal,  building a portfolio of unique high value specialty silicon products needed for the coming RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAP™ “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;
       °  HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
  • The PUREVAP™ Nano Silicon Reactor (NSiR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
       °  HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;
       °  During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAP™ SiNR.

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
       °  The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries.
       °  The plan is to deliver porous Si wafer to a battery manufacturer (under NDA) for testing in 2020.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

Tags: , , , , ,
Posted in HPQ-Silicon Resources Inc. | Comments Off on PyroGenesis $PYR.ca Participates in $HPQ.ca Non-Brokered Private Placement Financing $IDK.ca $DUK $XEL $NEE

Datametrex $DM.ca Applies to Health Canada for 5 Minute Fast Antigen Kit

Posted by AGORACOM-JC at 8:18 AM on Tuesday, September 1st, 2020
http://www.smallcapepicenter.com/DM%20square.png
  • Announced that the Company has submitted a Medical Devices Interim Order Request Form to approve PCL, Inc.’s COV05 COVID19 Rapid Antigen Detection Kits to Health Canada
  • Application is made under IO Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act signed by the Minister of Health on August 24, 2020, for PCLCOV05 COVID19 Rapid Antigen Detection Kits.

TORONTO, Sept. 01, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF ) is pleased to announce that the Company has submitted a Medical Devices Interim Order (“IO”) Request Form to approve PCL, Inc.’s (“PCL”) COV05 COVID19 Rapid Antigen Detection Kits to Health Canada.

This application is made under IO Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act signed by the Minister of Health on August 24, 2020, for PCLCOV05 COVID19 Rapid Antigen Detection Kits. This IO will allow Health Canada to issue expedited review and approval for the sale of these test kits in Canada.

The Company has represented to Health Canada that it will be able to provide a minimum first order of 200,000, followed by an additional 200,000 units on a weekly basis. Any purchase of the test kits by the Canadian government is conditional on prior receipt of Health Canada approval.

These test kits are suitable for point of care tests. No extra equipment is needed. They are simple to use and results are available in 10 minutes.

“According to the manufacturer, PCL, this test can detect antigens of COVID-19 from a swab in the nose and throat to provide results in 5-10 minutes with over 86% accuracy,” said Marshall Gunter, CEO of Datametrex. “These almost-instant kits can be easily used at home. With the rise of cases in the United States and throughout the world, we at Datametrex believe it is critical to test and protect.”

View the PCL Antigen test manual video by clicking the link: PCL COVID-19 ANTIBODY TEST – COV0

According to PCL the clinical sensitivity (confirmed the actual positive of the approved person where approved person tested positive with a PCR nucleic test) is 86.49% and the clinical specificity (confirmed the actual negative of the negative person where the negative person tested negative with a PCR nucleic test) is 97.87%*. Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.

The following certifications have been awarded to these PCL Antigen Test Kits: CE Certificate, Korea KPMG, FIND Listed, UNGM Supplier. Countries includes the EU, 2 countries in the Middle East- Qatar and UAE, India, Russia, 3 countries in Latin America- Guatemala, Ecuador, and Colombia.

The PCL Inc Antigen Detection kit has the CE Certificate meaning that the manufacturer and products have met EU declaration of standards for health, safety, and environmental protection, allowing this product to be sold within the 22 countries in the European Economic Area.

Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company plans to sell these kits in all countries where the kits have been approved for sale. Datametrex anticipates that it will have little or no upfront costs associated with importing these test kits. Assuming Health Canada approves the test kits and they are subsequently purchased by the Canadian government, manufacturer will ship the test kits directly to the Canadian government or hospitals, and Datametrex will not be involved in the shipping, warehousing or distribution process.

* Clinical Accuracy

The clinical performance of the PCL COVID-19 Ag Rapid FIA was evaluated in two different institutions compared to RT-PCR positive cases. Positive percent is 86.49% (95% CI: 70.43-94.92%) and negative percent agreement is 97.87% (95% CI: 87.28%-99.89%) in the PCL COVID-19 Ag Ripid FIA.

COVID-19 Ag Ripid FIA.RT – PCRPPA (%)NPA (%)
POSNEG
Site 1POS200100.0096.00
NEG020
Total2020
Site 2POS12170.59100.00
NEG526
Total1727
TotalPOS32186.4997.87
NEG546
Total3747

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Applies to Health Canada for 5 Minute Fast Antigen Kit

Esports Entertainment Group $GMBL Strengthens Board with New Independent Director $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 8:15 AM on Tuesday, September 1st, 2020
Esports Entertainment Group Strengthens Board with New Independent Director
  • Announced gambling industry veteran Warwick Bartlett was appointed to the Company’s Board as an independent director
  • Warwick was chairman of the Association of British Bookmakers for 10 years, chairman of the Bookmakers Committee to the Levy Board for six years and held a seat on the Horserace betting Levy Board for the same period.
  • Esports Entertainment Group CFO Dan Marks also appointed to the Company’s Board

BIRKIRKARA, Malta, Sept. 01, 2020 — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, today announced gambling industry veteran Warwick Bartlett was appointed to the Company’s Board as an independent director. Esports Entertainment Group CFO Dan Marks also appointed to the Company’s Board.

Warwick was chairman of the Association of British Bookmakers for 10 years, chairman of the Bookmakers Committee to the Levy Board for six years and held a seat on the Horserace betting Levy Board for the same period. Warwick is the CEO and owner of Global Betting & Gaming Consultants (GBGC), which has established itself as the most credible specialist international gambling consultancy in the world. GBGC has worked with, or supplied information to, over 600 clients, the majority of whom are “blue chip.” Projects have included market research/assessments, business/facility planning, product evaluations, design/operational reviews, the development/review of corporate strategies, license applications, regulation development for and on behalf of governments, IPOs, M&A and due diligence. Typically, clients include operators, monopolies/lotteries, suppliers, investment banks, the major consultancies, and governments.

“I am delighted to join Esports Entertainment Group’s Board as a non-executive director, and l look forward to working with Grant and his accomplished team,” commented Warwick. “There are some wonderful opportunities in esports gaming, such as the Company’s recent acquisition of Argyll Entertainment, which provides Esports Entertainment Group with immediate revenue and the foundation for accelerated growth.”

Global esports revenues are expected to grow 15.7% year-on-year to $1.1 billion in 2020, according to Newzoo, while the global esports betting market is forecast to reach $17.2 billion by year end according to data from Esports Insider.

“Warwick has been instrumental in several major developments in the gambling and iGaming space, and we’re excited to have him on the team,” said Grant Johnson, CEO of Esports Entertainment Group. “He’s a strong addition to the board as an independent director, and I believe his experience will resonate with the institutional investor community.”

“We have laid the foundation for long-term success with the world’s most transparent esports betting platform,” continued Johnson. “With a strong team, industry-leading partnerships, and significant competitive advantages, Esports Entertainment Group is well positioned for rapid growth in the months ahead.”

ABOUT ESPORTS ENTERTAINMENT GROUP

Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fixed odds wagering, fantasy and pools on various esports events in a licensed, regulated and secure platform at vie.gg and owns and operates online sports book, SportNation.bet. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multiplayer mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in the UK, Ireland, Malta and Curacao. The Company maintains offices in New Jersey, the UK and Malta. For more information visit www.esportsentertainmentgroup.com.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations 
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Media Contacts
AGORACOM
[email protected]
http://agoracom.com/ir/eSportsEntertainmentGroup

Brian Fisher
Allied Esports
[email protected]

Tags: , , , ,
Posted in Esports Entertainment Group, Esports Entertainment Group Inc., eSports Investing, Featured | Comments Off on Esports Entertainment Group $GMBL Strengthens Board with New Independent Director $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

ThreeD Capital Inc. $IDK.ca $IDKFF Provides Corporate Developments $IP.ca $IPNFF $GMBL

Posted by AGORACOM-JC at 7:39 AM on Tuesday, September 1st, 2020
IDK-square-for-blog
  • Company is pleased to announce it is now disclosing the number of junior resource and technology investments on its newly designed website and will update these figures at the commencement of each month
  • In the last month, ThreeD increased the number of junior resource investments from 12 to 15, representing a 25% increase month over month
  • The Company plans to continue to grow its junior resource portfolio for the foreseeable future

TORONTO, Sept. 01, 2020 — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQB:IDKFF) a Canadian based venture capital firm that invests in disruptive companies and promising junior resources companies, is pleased to provide a general corporate update to shareholders.

ThreeD is actively investing in the junior resource sector and has significantly grown its number of junior resource investments for the last 3 consecutive months.

The Company is pleased to announce it is now disclosing the number of junior resource and technology investments on its newly designed website and will update these figures at the commencement of each month. In the last month, ThreeD increased the number of junior resource investments from 12 to 15, representing a 25% increase month over month. The Company plans to continue to grow its junior resource portfolio for the foreseeable future.   

ThreeD previously reported in its continuous disclosure documents that it had sold pursuant to a share purchase agreement dated November 15, 2019, an aggregate of 13,500,000 common shares of New Found Gold Corp. to a third party purchaser at a price of $0.08 per share for aggregate proceeds of $1,080,000. The Company has since commenced a legal action claiming rescission of the transaction or, in the alternative, damages in the approximate amount of $16,000,000 or the present value of the common shares. The Company is currently arranging with the third party dates and times for discoveries in this action.  The Company believes that the purchaser was in possession of information material to the transaction that was not disclosed at the time. It is not determinable if the Company will be successful in its claim or, if successful, the amount of damages that may be awarded, if any.

About ThreeD Capital Inc.

ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the Junior Resources, Artificial Intelligence, Blockchain, Esports, Renweable Technology, Internet of Things, & Nanotechnology sectors. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and is actively involved with investees by advising and leveraging ThreeD’s powerful network.

Forward-Looking Statements

This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws including, without limitation, statements with respect to the legal action concerning the common shares of New Found Gold Corp. (the “Litigation”). All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur including, without limitation, risks relating to the timing, costs and potential outcome of the Litigation. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.

For further information:
Gerry Feldman, CPA, CA
Chief Financial Officer and Corporate Secretary
[email protected]
Phone: 416-941-8900 ext 106

Tags: , , , , , , , , ,
Posted in Featured, ThreeD, ThreeD Capital | Comments Off on ThreeD Capital Inc. $IDK.ca $IDKFF Provides Corporate Developments $IP.ca $IPNFF $GMBL

Empower Clinics $CBDT.ca Announces Acquisition of Medical Diagnostics Laboratory $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:06 AM on Tuesday, September 1st, 2020

Empower intends to acquire Kai Medical Laboratory, a state-of-the-art diagnostics laboratory located in the medical district of Dallas, TX to advance COVID-19 national testing programs

  • Entered into a non-binding term sheet to acquire the business of Kai Medical Laboratory, LLC, by way of a share or asset acquisition, subject to due diligence and customary closing conditions
  • Kai Medical Laboratory is a high-complexity CLIA and COLA accredited Laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups
  • Kai Medical Laboratory offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology

VANCOUVER, BC / September 1, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) (“Empower” or the “Company“) today announces it has entered into a non-binding term sheet to acquire the business of Kai Medical Laboratory, LLC (“Kai Medical Laboratory“), by way of a share or asset acquisition, subject to due diligence and customary closing conditions.

Kai Medical Laboratory is a high-complexity CLIA and COLA accredited Laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups. Kai Medical Laboratory offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology. These tests are done under the supervision of its well-qualified and highly experienced scientists, medical professionals, and pharmacists. https://www.kaimedicallaboratory.com

Kai Medical Laboratory has taken an active role in COVID-19 testing, battling the pandemic through RT-PCR testing and serology testing. While the RT-PCR test identifies if a patient has an active virus, the serology or antibody test detects if a patient has previously been exposed to the virus. Both of these test results are vital to managing outbreaks and the potential spread of coronavirus.

To further assist with COVID-19 testing, Kai Medical Laboratory has also developed two key programs in Texas and Arizona. The first program is a direct-to-consumer program that leverages the ability of various healthcare providers to order and administer both the RT-PCR test and the Antibody test. This increases the ability of the general population to be tested, in certain circumstances. The second is an Employer COVID-19 Compliance Program (ECCP) for business owners and employer groups to enable them to test and monitor their employees.

Texas program https://www.testtexasnow.com

Arizona program https://www.covidtest2u.com

Currently the lab has the capacity to complete in excess of 2,000 RT-PCR tests in one eight-hour shift by utilizing its Thermo Fisher QuantStudio 12k Flex testing machine. The lab also utilizes a Roche Cobas 6000 for COVID-19 Antibody testing, ensuring that Kai Medical Laboratory has the capability and capacity to serve a broad range of clients and test methods.

“Adding Kai Medical Laboratory to the Empower Clinics family enables us to dramatically expand COVID-19 testing capability and deliver phase four of our national rollout plan” said Steven McAuley, Empower’s Chairman & CEO. “Kai Medical has a newly built high-complexity lab offering a wide array of testing services, that together we will leverage to serve the massive demand for national COVID testing in the U.S. Further, as flu season arrives and a potential second-wave of COVID takes hold, the technical infrastructure of Kai Medical allows Empower to capture testing demand and the additional growth revenues associated with it.”

The driving force behind Kai Medical Laboratory’s remarkable growth and success is Yoshi Tyler. Yoshi has a passion for being an entrepreneur, and overtime, she found her true calling in healthcare. Driven by this interest, she pursued her career in the healthcare industry for more than two decades. She helmed leadership positions at a Fortune 500 pharmaceutical company for over thirteen years. These leadership experiences provided her with in-depth knowledge and industry insights that helped her to lead Kai Medical Laboratory towards growth.

The Kai Medical Laboratory team includes key roles including Principal Scientist, Director of Operations, Molecular Scientist, Quality Assurance, Lab Director and other critical roles.

“Kai Medical Laboratory is inspired by science and built on integrity. Our mission is to change healthcare through science & innovative quality care by providing value-added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in healthcare,” says Yoshi Tyler, the owner, and CEO of the company.

The proposed acquisition includes an 8,000 sq. ft. medical laboratory including covered drive up testing center, with premium testing and laboratory equipment, cash and current assets with a value in excess of $1,750,000.00 USD and a corporate office, both located in the heart of the medical district in Dallas, TX. Under the proposed terms Empower will assume a $1,200,000.00 USD Small Business Administration (SBA) equipment loan, a $150,000.00 SBA Economic Injury Disaster Loan and short-term liabilities of up to $250,000.00 at closing. In addition, Empower will issue 1,000,000 Company stock options to the Vendors, subject to the terms and conditions as set out in the Company Stock Option Plan.

Market Leading Technology Kai Medical Laboratory utilizes state-of-the-art instrumentation, preeminent testing methodologies, and laboratory services enabling high-complexity accredited laboratory testing solutions, providing some of the following key instrument testing capabilities:

  • Thermo Fisher – QuantStudio 12K Flex
    • COVID-19 testing
    • Cannabis Testing
    • Clinical Genomics
  • Roche Cobas 6000
    • COVID-19 Antibody testing
    • Clinical Chemistry/Endocrinology
  • AB SCIEX 6500+ – Liquid Chromatography Mass Spectrometry
    • Clinical Chemistry/Endocrinology
    • Agriculture/Cannabis testing
  • AB SCIEX 4500 – Liquid Chromatography Mass Spectrometry
    • Urine Toxicology
    • Cannabis testing
  • SYSMEX XN-550
    • Hematology

USA COVID-19 Data as at August 31, 2020

TOTAL CASES: 5,972,356

TOTAL DEATHS: 182,622

CASES IN LAST 7 DAYS: 289,865

ARIZONA as at August 31, 2020

CONFIRMED CASES: 199,984

PROBABLE CASES: 1,713

TOTAL CASES: 201,661

CASES IN LAST 7 DAYS: 3,558

CASES/100K: 1,769

DEATHS/100K: 70

TEXAS as at August 31, 2020

TOTAL CASES: 610,354

CASES IN LAST 7 DAYS: 32,817

CASES/100K: 2,126

DEATHS/100K: 46

(CLIA) The Clinical Laboratory Improvement Amendments regulate laboratory testing and require clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing.

(COLA) is the premier clinical laboratory accreditation, education and consultation organization. An independent accreditor whose practical, educational standards have a positive and immediate impact on patient care. http://www.cola.org

The transaction is expected to be structured on a tax efficient basis, and otherwise in accordance with the requirements of requisite securities laws and the policies of the CSE. Empower has agreed to enter into employment agreements with Yoshi Tyler and Michael Haines, each having an initial term of two years.

Completion of the transaction will be subject to various conditions, including entry into a definitive agreement, completion of due diligence, and receipt of all required shareholder, manager, third party and regulatory approvals, including approval of the CSE. Closing of the transaction is expected to occur prior to October 15, 2020.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative.

ABOUT KAI MEDICAL LABORATORY

Our mission is to change healthcare through science & innovative quality care by providing value added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in patient care. Kai Medical Laboratory is located in the Dallas Medical District in close proximity to some of the largest healthcare groups in the U.S. including Parkland Hospital, UT Southwestern, Children’s Medical Center, Baylor Scott & White Health (Dallas), Tenet Healthcare (Dallas), CHRISTUS Healthcare (Dallas).

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Dustin Klein

Director
[email protected]
720-352-1398

Investors: Steven McAuley

CEO
[email protected]
604-789-2146

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the proposed acquisition of Sun Valley; the proposed transaction terms; the expected number of clinics and patients following the closing; the future potential success of Sun Valley’s franchise model; the anticipated date of closing of the acquisition and the occurrence thereof; and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Kai Medical Laboratory acquisition may not be completed on the terms expected or at all; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse affect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

Tags: , , , , , , , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Announces Acquisition of Medical Diagnostics Laboratory $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Datametrex $DM.ca Appoints New Chief Financial Officer

Posted by AGORACOM-JC at 7:57 PM on Monday, August 31st, 2020
http://www.smallcapepicenter.com/DM%20square.png
  • Announced the appointment of Don Shim, CPA, CA as the new Chief Financial Officer
  • This new addition to the Company’s executive leadership team brings nearly 20 years of financial experience in accounting and financial control along with a combination of private and public companies in a variety of industries.

TORONTO, Aug. 31, 2020 — Datametrex AI Limited (“Datametrex” or the “Company“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Don Shim, CPA, CA as the new Chief Financial Officer (“CFO”).

This new addition to the Company’s executive leadership team brings nearly 20 years of financial experience in accounting and financial control along with a combination of private and public companies in a variety of industries. These include cannabis, resource, and financial services. Don will work to ensure Datametrex’s financial health through strategic planning and management of the company’s finances.

  • Mr. Shim has led a successful accounting and finance career in both the US and Canada. He brings a wealth of knowledge to the team with his expertise in auditing publicly- traded junior mining companies and high-tech industries. Member of the Chartered Professional Accountants of British Columbia and a Certified Public Accountant registered in the State of Illinois, United States.
  • Audit partner on numerous audit engagements for various publicly traded companies, primarily focusing on junior mining, oil and gas, pharmaceutical, and high-tech industries.
  • Mr. Shim also assisted various start-up companies in achieving public listings on the TSX Venture Exchange, Canadian Securities Exchange and the OTC Market.
  • In addition, Mr. Shim teaches accounting at a local college in Vancouver and acts as a facilitator at CPA Western School of Business, mentoring CPA candidates enrolled in the CPA Professional Education Program.

“I am thrilled to join Datametrex and this impressive leadership team with a history of growing great companies, and I am happy to be a part of this enterprise,” said Don.

“On behalf of the executive team and our Board of Directors, I would like to thank Steve Kang for his dedication and hard work during his tenure as CFO. I wish Steve nothing but success in his future endeavours,” said Paul Haber, audit committee chair of the Company.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , ,
Posted in Datametrex AI Limited | Comments Off on Datametrex $DM.ca Appoints New Chief Financial Officer

« Older Entries
Newer Entries »